These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16475970)

  • 41. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemogenomics: a discipline at the crossroad of high throughput technologies, biomarker research, combinatorial chemistry, genomics, cheminformatics, bioinformatics and artificial intelligence.
    Maréchal E
    Comb Chem High Throughput Screen; 2008 Sep; 11(8):583-6. PubMed ID: 18795877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A chemoinformatics analysis of hit lists obtained from high-throughput affinity-selection screening.
    Brown N; Zehender H; Azzaoui K; Schuffenhauer A; Mayr LM; Jacoby E
    J Biomol Screen; 2006 Mar; 11(2):123-30. PubMed ID: 16361695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Data structures and computational tools for the extraction of SAR information from large compound sets.
    Wawer M; Lounkine E; Wassermann AM; Bajorath J
    Drug Discov Today; 2010 Aug; 15(15-16):630-9. PubMed ID: 20547243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-throughput virtual screening for drug discovery in parallel.
    Toledo-Sherman LM; Chen D
    Curr Opin Drug Discov Devel; 2002 May; 5(3):414-21. PubMed ID: 12058617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Image-based chemical screening.
    Carpenter AE
    Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Computational chemistry-driven decision making in lead generation.
    Schnecke V; Boström J
    Drug Discov Today; 2006 Jan; 11(1-2):43-50. PubMed ID: 16478690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fragment analysis in small molecule discovery.
    Merlot C; Domine D; Church DJ
    Curr Opin Drug Discov Devel; 2002 May; 5(3):391-9. PubMed ID: 12058614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
    ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical genomics as an emerging paradigm for postgenomic drug discovery.
    Salemme FR
    Pharmacogenomics; 2003 May; 4(3):257-67. PubMed ID: 12718717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-high-throughput screening analysis: an empirical compound prioritization scheme.
    Oprea TI; Bologa CG; Edwards BS; Prossnitz ER; Sklar LA
    J Biomol Screen; 2005 Aug; 10(5):419-26. PubMed ID: 16093551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tackling the chemogenomic space by novel screening technologies.
    Mayr LM
    Ernst Schering Res Found Workshop; 2006; (58):111-73. PubMed ID: 16709002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reporting data from high-throughput screening of small-molecule libraries.
    Inglese J; Shamu CE; Guy RK
    Nat Chem Biol; 2007 Aug; 3(8):438-41. PubMed ID: 17637769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combinatorial chemistry in drug discovery.
    Liu R; Li X; Lam KS
    Curr Opin Chem Biol; 2017 Jun; 38():117-126. PubMed ID: 28494316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The academic pursuit of screening.
    Nat Chem Biol; 2007 Aug; 3(8):433. PubMed ID: 17637766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
    Duffy BC; Zhu L; Decornez H; Kitchen DB
    Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.